Transferring Early-stage Drug, Biologics Research From West To East Will Speed Up Over Next Five Years
This article was originally published in PharmAsia News
Executive Summary
BEIJING - A survey of leaders of U.S. pharmaceutical and biotech firms conducted by Citi Investment Research and Analysis indicates that outsourcing early-stage research to scientists at contract research organizations in China and India could see high-speed expansion over the next five years